The Boston Scientific Ranger Drug-Coated PTA Balloon Catheter (REF H74939670702090) is a paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter engineered to deliver an antiproliferative drug to the vessel wall during peripheral angioplasty procedures. Featuring a 7 mm balloon diameter and 200 mm balloon length, this device combines mechanical dilatation with localized drug transfer in a single procedural step.
Key Features
Paclitaxel drug-coated balloon surface intended for localized drug delivery to the vessel wall.
Balloon diameter: 7 mm.
Balloon length: 200 mm.
TransPax coating technology designed to support efficient drug transfer with low particulate loss (per manufacturer literature).
Low-profile balloon design intended to facilitate crossing and tracking through tortuous peripheral anatomy.
Over-the-wire catheter platform compatible with standard 0.035 inch guidewires (verify with current IFU).
Working length: Not specified in the located sources.
Sheath compatibility and rated burst pressure: Not specified in the located sources.
Clinical Applications
Indicated for use in percutaneous transluminal angioplasty of peripheral arteries, as described in the manufacturer Instructions for Use.
Commonly considered for treatment of stenotic or occlusive lesions in the superficial femoral artery (SFA) and popliteal artery segments.
Suitable for cases where clinicians select a drug-coated balloon strategy following standard pre-dilatation, in accordance with institutional protocols and the device IFU.
Product Information
Brand: Boston Scientific
Product Line: Ranger Drug-Coated PTA Balloon Catheter
Category: Peripheral Balloon Catheters
REF / UPN: H74939670702090
Balloon Size: 7 mm x 200 mm
Drug Coating: Paclitaxel (TransPax coating technology)
Packaging: Single-use, sterile (refer to product label)
Regulatory and clinical use: Refer to the current manufacturer Instructions for Use and applicable local regulatory clearances for indications, contraindications, warnings, and precautions.